"Our job is to look at the application and decide whether there is a positive benefit risk," the EMA executive director Emer Cooke told the Herald. "We will outline the indication for the vaccines for the type of population it shows positive outcomes for. Prof O'Neill said another drug company Johnson and Johnson is also due to announce results, holding out the possibility that we will have four vaccines. One of the dosing patterns used by the scientists suggested 90pc effectiveness if one half dose is given followed by a full dose. Another dosing pattern showed 62pc efficacy when one full dose is given followed by another full dose.

Source: The Herald November 24, 2020 02:30 UTC